On April 22, 2022 Alligator Bioscience will host a conference call (in English) for investors, analysts and media on Wednesday, April 27, 2022, at 15:30 CET (Press release, Alligator Bioscience, APR 22, 2022, View Source [SID1234612805]). Alligator will publish the company’s interim report on Wednesday, April 27, 2022, at 8:00 CET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

CEO, Søren Bregenholt and CFO, Marie Svensson will present the interim report for the period January – March 2022 Report followed by a Q&A session.

The conference call will be broadcast live on the web and can be accessed via the link: Alligator Bioscience , Audiocast with teleconference, Q1, 2022 | Financial Hearings